Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : IMDS nasdaq bulletin board -- Ignore unavailable to you. Want to Upgrade?

To: KAKALAK who wrote (4018)	1/19/2000 10:26:00 PM
From: ESPAUL	Read Replies (1) \| Respond to of 4122

Follow-up from RB: By: AndrewAbraham Reply To: None Wednesday, 19 Jan 2000 at 4:23 PM EST Post # of 6120 Johns Hopkins update: Please bear with me while the spokesperson at Johns Hopkins gets to the bottom of this. The spokesperson sent me the message this morning which I relayed here. It said that Johns Hopkins has declined to be a clinical test site or to participate in the FDA trial. When I got this message, I called to confirm the information and asked if it was o.k. to post it. I was told yes. I then received a message that the information may be incomplete or not correct. The spokesperson has received conflicting information and is now trying to get to find out which is true. I will post information as soon as I get it. If any of the information was incorrect, I will apologize for posting it. I've also asked RB to remove that post, because of the possibility that it may contain incorrect information about that rumor. I am very sorry for this confusion. I hope by the end of the day to be able to clear this up.